Sinclair-pharma Recognized Providers
Sinclair Pharma
Sinclair Pharma is a global medical aesthetics company specialising in the development, manufacturing and commercialisation of injectable and energybased aesthetic treatments as well as advanced aesthetic devices, supporting clinicians with tools and solutions for skin rejuvenation, collagen stimulation and holistic aesthetic practice.Overview
Founded Year: 1971
Founder:
Purpose: To innovate and provide sciencedriven, highquality aesthetic medicine products that enable clinicians to deliver safe, effective and advanced treatments for aesthetic enhancement and skin health.
Governing Body
Organisation Name: Sinclair Pharma Limited
Company Status: Subsidiary of Huadong Medicine Company Limited (public pharmaceutical company)
Regulatory Status: Operates under international health authority regulatory frameworks for product approvals and distribution
Industry Standing: Recognised international aesthetic medicine brand with products available in over 55 countries and a robust global commercial and distribution network.
Eligibility Criteria
Who Can Apply:
Requirements:
Restrictions:
Judging Criteria
Evaluation Factors:
Categories
Available Categories:
Injectable aesthetic products (e.g., collagen stimulators, dermal fillers)Energy‑based devices and aesthetic platformsAdvanced skincare and aesthetic technologies
Accreditation Requirements
Inspection Required:
Documentation Required:
Compliance Standards:
Regulatory marketing authorisations in applicable ...Good manufacturing practice and safety compliance ...
Sources:
Verification Process
Public Register:
Certificate Validation Method:
Sources:
Renewal & Compliance
Renewal Frequency:
CPD Requirements:
Audit Process:
Sources:
Benefits
Reputation: Sinclair Pharma is widely recognised by clinicians and aesthetic professionals for it's portfolio of advanced products such as Silhouette InstaLift, Ellans' and energybased devices, supporting clinical practice globally.
Patient Trust Impact: Products backed by clinical data and regulatory approvals help clinicians build patient confidence in safe treatment outcomes.
Patient Safety Impact
Mechanisms of Protection:
Sinclair’s aesthetic products undergo clinical evaluation and regulatory clearances prior to market launch in applicable regions.Training and product support for clinicians emphasise safe practice and evidence‑based protocols.
Limitations:
Sinclair does not itself provide practitioner credentials or regulatory certification of clinician competence.Safety and outcomes depend on appropriate use by licensed healthcare professionals.
Comparison with Other Bodies
Comparable Entities:
Allergan Aesthetics (AbbVie)Other global aesthetic medicine product manufacturers
Key Differences:
Sinclair focuses exclusively on aesthetic medicine products with a holistic portfolio of injectables and devices, while some competitors operate broader pharmaceutical portfolios.Sinclair’s global distribution is complemented by in‑house commercial infrastructure and partnerships.
Industry Recognition
Media Mentions:
Product launch announcements such as Préime DermaFacial and strategic licensing agreements highlight Sinclair’s industry impact.Coverage of product approvals and international expansion emphasize Sinclair’s growth in aesthetic markets.
Endorsements:
Credibility Signals:
Headquartered in London with subsidiary status under Huadong Medicine, Sinclair’s products are used in more than 55 countries.Partnerships and licensing deals with global aesthetic technology and product developers.
Government Regulation Status
Statutory Backing:
Regulated By: Subject to regulatory oversight by health authorities such as FDA, EMA, Health Canada and others for product approvals.
Legal Status: Aesthetic pharmaceutical product company operating within national and international regulatory frameworks for medical devices and injectable products.
